← Open Payments lookup

SHUBA SRINIVASAN: Open Payments

NPI 1497702328 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$820 in 35 payments from 19 companies in 2025. Trend: 2023 $176 · 2024 $522 · 2025 $820

Food & beverage: $820
CompanyPaymentsAmount
Merck Sharp & Dohme LLC4$100
Myriad Genetic Laboratories, Inc.2$94
ABBVIE INC.4$93
Incyte Corporation4$83
Janssen Biotech, Inc.4$67
Celgene Corporation3$63
AstraZeneca Pharmaceuticals LP2$45
Gilead Sciences, Inc.1$34
SERVIER PHARMACEUTICALS LLC1$30
Alnylam Pharmaceuticals Inc.1$28

Products named: KEYTRUDA, MYRISK, EPKINLY, MONJUVI, REBLOZYL, JAKAFI, Trodelvy, Tibsovo.

Industry payments across TX — which companies pay providers there.